The safety of biological pharmacotherapy for the treatment of ulcerative colitis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The safety of biological pharmacotherapy for the treatment of ulcerative colitis
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 16, Issue 4, Pages 437-443
Publisher
Informa UK Limited
Online
2017-03-10
DOI
10.1080/14740338.2017.1298743
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study
- (2016) D. C. Baumgart et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents
- (2016) Jordan Axelrad et al. Clinical Gastroenterology and Hepatology
- Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis
- (2016) Stefanos Bonovas et al. Clinical Gastroenterology and Hepatology
- The safety of vedolizumab for ulcerative colitis and Crohn's disease
- (2016) Jean-Frédéric Colombel et al. GUT
- Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease
- (2016) Benjamin Alexandre et al. Journal of Crohns & Colitis
- Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis
- (2016) Chelle L. Wheat et al. Gastroenterology Research and Practice
- A Case of Adalimumab-Induced Pneumonitis in a 45-Year-Old Man with Crohn’s Disease
- (2016) James D Reid et al. Canadian Respiratory Journal
- Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study
- (2015) D. Pugliese et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cumulative Incidence of, Risk Factors for and Outcome of Dermatological Complications of Anti-TNF Therapy in Inflammatory Bowel Disease: A 14-Year Experience
- (2015) Estelle Fréling et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials
- (2015) Anthony Lopez et al. DIGESTIVE AND LIVER DISEASE
- Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the Risk
- (2015) László Herszényi et al. DIGESTIVE DISEASES
- Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis
- (2015) Sylvie Pillet et al. INFLAMMATORY BOWEL DISEASES
- European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
- (2015) Vito Annese et al. Journal of Crohns & Colitis
- The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
- (2015) Marcus Harbord et al. Journal of Crohns & Colitis
- Vedolizumab Effectiveness and Safety Over the First Year of Use in an IBD Clinical Practice
- (2015) Emily E. Vivio et al. Journal of Crohns & Colitis
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2 and 3
- (2014) Jean-Frederic Colombel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Biological Agents for Moderately to Severely Active Ulcerative Colitis
- (2014) Silvio Danese et al. ANNALS OF INTERNAL MEDICINE
- Development of Drugs to Target Interactions Between Leukocytes and Endothelial Cells and Treatment Algorithms for Inflammatory Bowel Diseases
- (2014) Silvio Danese et al. GASTROENTEROLOGY
- Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results
- (2014) Tim Wyant et al. GUT
- Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2014) J.F. Rahier et al. Journal of Crohns & Colitis
- Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System
- (2013) P. Deepak et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents
- (2013) Gionata Fiorino et al. AUTOIMMUNITY REVIEWS
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- European evidence based consensus for endoscopy in inflammatory bowel disease
- (2013) Vito Annese et al. Journal of Crohns & Colitis
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Pooled Analysis of Infections, Malignancy and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease
- (2012) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study
- (2012) Parakkal Deepak et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
- (2012) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Infliximab-Induced Nonspecific Interstitial Pneumonia
- (2012) Soumitra Sen et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Extracorporeal Photopheresis (ECP) in Patients with Steroid-dependent Crohnʼs Disease
- (2012) Walter Reinisch et al. INFLAMMATORY BOWEL DISEASES
- Aging, cancer, and cancer vaccines
- (2012) Paolo Mazzola et al. Immunity & Ageing
- Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy
- (2011) S. Danese et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Role of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel Disease
- (2011) Lisa J Herrinton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Is Inflammatory Bowel Disease an Important Risk Factor Among Older Persons with Colorectal Cancer in the United States? A Population-Based Case–Control Study
- (2011) Aasma Shaukat et al. DIGESTIVE DISEASES AND SCIENCES
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- AGA Medical Position Statement on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
- (2010) Francis A. Farraye et al. GASTROENTEROLOGY
- Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register
- (2010) W. G. Dixon et al. ARTHRITIS CARE & RESEARCH
- Peripheral neuropathy in inflammatory bowel disease patients: A prospective cohort study
- (2009) Samia Ben Sassi et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
- (2008) H Fidder et al. GUT
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now